Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

FDA IND clearance for Trace Biosciences’ nerve-specific imaging agent

Jim Cornall - February 2, 2026

biotech

Lilly injectable medicine and device manufacturing facility to be built in Pennsylvania

Jim Cornall - February 2, 2026

biotech

A broken DNA repair tool accelerates aging

Jim Cornall - February 2, 2026

biotech

Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immuno-oncology company collaborate

Jim Cornall - January 30, 2026

biotech

Two-faced nanoparticles help antibiotics treat resistant bacteria

Jim Cornall - January 29, 2026

biotech

Resolve M Therapeutics exits from stealth

Jim Cornall - January 29, 2026

biotech

New cancer treatment options through expanding ADC payload spectrum

Jim Cornall - January 29, 2026

biotech

Why tumours become aggressive and genetically unstable

Jim Cornall - January 28, 2026

1...252627...78 Page 26 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0